Combining surgery with chemotherapy significantly improves survival in GIST patients with liver metastases compared to chemotherapy alone. Median CSS and OS for combined treatment exceed 120 months, ...
Neoadjuvant TKI therapy in non-metastatic GIST patients can reduce surgical complexity, with CE-CT imaging predicting benefits in 22 of 39 patients. Significant tumor volume reduction was observed ...
The benefit of cytoreductive surgery during imatinib (IM) therapy in patients with metastatic gastrointestinal stromal tumors (mGISTs): Retrospective analysis from several cancer centers.
Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk locally advanced stage gastrointestinal stromal tumor.
These study authors hope their findings will inform future research on gastrointestinal stromal tumors (GIST) and close care gaps for minority patient populations. Unfavorable trends in the diagnosis ...
LONDON, June 25 (Reuters) - Glivec, from Novartis , should not be used in patients who have had a gastrointestinal stromal tumour (GIST) removed by surgery, Britain's health cost watchdog said in ...
LONDON (Reuters) - Glivec, from Novartis, should not be used in patients who have had a gastrointestinal stromal tumour (GIST) removed by surgery, the health cost watchdog said in draft guidance on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results